iSpecimen
ISPC
13 hedge funds and large institutions have $781K invested in iSpecimen in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% more funds holding
Funds holding: 13 → 13 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
4% less capital invested
Capital invested by funds: $813K → $781K (-$32K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$229K |
| 2 |
VF
Virtu Financial
New York
|
+$23.3K |
| 3 |
GC
Grimes & Company
Westborough,
Massachusetts
|
+$7.16K |
| 4 |
Morgan Stanley
New York
|
+$7.16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$43K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$3.58K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $270K | +$229K | +128 | +166% |
|
|
BL
2
Bleichroeder LP
New York
| $109K | – | – | – |
|
|
GC
3
Grimes & Company
Westborough,
Massachusetts
| $108K | +$7.16K | +4 | +5% |
|
4
BlackRock
New York
| $94K | – | – | – |
|
|
TA
5
Teton Advisors
Rye,
New York
| $66K | – | – | – |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $35K | -$3.58K | -2 | -7% |
|
|
SSA
7
Schonfeld Strategic Advisors
New York
| $34K | +$1.79K | +1 | +4% |
|
|
VF
8
Virtu Financial
New York
| $18K | +$23.3K | +13 | New |
|
|
MSFS
9
Main Street Financial Solutions
Newtown,
Pennsylvania
| $17K | – | – | – |
|
|
10
Morgan Stanley
New York
| $13K | +$7.16K | +4 | +67% |
|
|
11
UBS Group
Zurich,
Switzerland
| $9K | +$7.16K | +4 | +133% |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $6K | -$1.79K | -1 | -17% |
|
13
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$43K | -25 | Closed |
|
ISPC Hedge Fund Activity: Q3 2022 in Review
13 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q3 2022, worth a combined $781K — down 3.9% from $813K a quarter earlier.
Fund positioning in ISPC was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $229K. The largest seller was Citadel Advisors, exiting entirely with an estimated $43K sold.
- 13 institutional investors held iSpecimen (ISPC) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $781K of iSpecimen stock for Q3 2022, down 3.9% quarter-over-quarter.
- 1 fund opened new iSpecimen positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest iSpecimen buyer in Q3 2022 was Vanguard Group, an estimated $229K added.
- The largest iSpecimen seller in Q3 2022 was Citadel Advisors, an estimated $43K sold.
Based on aggregated 13F filings for Q3 2022.